Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis

E-ISSN： 1873-4286|19|30|5344-5361

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.30, 2013-09, pp. : 5344-5361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topics: Naturally Occurring Molecules and Anticancer Combination Therapies in the Era of Personalized Medicine and Economic Crisis)

Current Pharmaceutical Design, Vol. 19, Iss. 30, 2013-09 ,pp. : 5325-5326

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapies in Bone Sarcomas

Current Cancer Drug Targets, Vol. 9, Iss. 7, 2009-01 ,pp. : 843-853

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapies gain ground against multiple myeloma

Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The miRNA–drug resistance connection: a new era of personalized medicine using noncoding RNA begins

By Mishra Prasun J

Pharmacogenomics, Vol. 13, Iss. 12, 2012-09 ,pp. : 1321-1324

Future Medicine

Access to resources Recommend Favorite

The Post-2015 Agenda: Complexity Theory-Based Governance of the Global Health System in the Era of Postgenomics and Personalized Medicine

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 4, 2013-12 ,pp. : 309-311

Bentham Science Publishers

Access to resources Recommend Favorite